Literature DB >> 11744234

Contribution of endothelium-derived relaxing factors to P2Y-purinoceptor-induced vasodilation in the isolated rat kidney.

R Wangensteen1, O Fernández, J Sainz, A Quesada, F Vargas, A Osuna.   

Abstract

We examined the role of endothelium-derived relaxing factors nitric oxide (NO), endothelium-derived hyperpolarising factor (EDHF), and prostaglandins (PGs) to P(2Y1)- and P(2Y2)-purinoceptor-induced vasodilation in isolated rat kidney. To do it, we analysed the renal response to ATP, 2-methylthio ATP, and UTP in rat renal vasculature under normal conditions and after the administration of: N(w)-nitro-L-arginine (L-NAME), increased K(+) concentration, indomethacin, and L-NAME and increased K(+) together. Our results indicate that the vasodilator response to P(2Y1)- and P(2Y2)-purinoceptor activation in the isolated perfused kidney of rats is subserved by EDHF and NO.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11744234     DOI: 10.1016/s0306-3623(01)00091-x

Source DB:  PubMed          Journal:  Gen Pharmacol        ISSN: 0306-3623


  5 in total

1.  A delayed ATP-elicited K+ current in freshly isolated smooth muscle cells from mouse aorta.

Authors:  Karima Serir; Sebastien Hayoz; Mohammed Fanchaouy; Jean-Louis Bény; Rostislav Bychkov
Journal:  Br J Pharmacol       Date:  2006-01       Impact factor: 8.739

2.  ATP, P2 receptors and the renal microcirculation.

Authors:  Edward W Inscho
Journal:  Purinergic Signal       Date:  2009-03-18       Impact factor: 3.765

Review 3.  Role of adenosine 5'-triphosphate in regulating renal microvascular function and in hypertension.

Authors:  Zhengrong Guan; Edward W Inscho
Journal:  Hypertension       Date:  2011-07-18       Impact factor: 10.190

4.  P2Y receptors and kidney function.

Authors:  Volker Vallon; James Stockand; Timo Rieg
Journal:  Wiley Interdiscip Rev Membr Transp Signal       Date:  2012-08-09

5.  Regional vascular responses to ATP and ATP analogues in the rabbit kidney in vivo: roles for adenosine receptors and prostanoids.

Authors:  G A Eppel; S Ventura; R G Evans
Journal:  Br J Pharmacol       Date:  2006-09-18       Impact factor: 8.739

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.